InnoCare Pharma Ltd.SSE: 688428

Announcement on Voluntary Disclosure of Approval by the Therapeutic Goods Administration of Australia for the Marketing of Orelabrutinib

· Issued by InnoCare Pharma Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-voluntary-disclosure-of-approval-by-the-therapeutic-goods-administration-of-australia-for-the-marketing-of-orelabrutinib

Release

Announcement on Voluntary Disclosure of Approval by the Therapeutic Goods Administration of Australia for the Marketing of Orelabrutinib

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

InnoCare Pharma Ltd. on 6ix

Earlier from InnoCare Pharma

Later from InnoCare Pharma

All InnoCare Pharma news releases